182 related articles for article (PubMed ID: 28699134)
1. Intraoperative Tumor Detection Using a Ratiometric Activatable Fluorescent Peptide: A First-in-Human Phase 1 Study.
Unkart JT; Chen SL; Wapnir IL; González JE; Harootunian A; Wallace AM
Ann Surg Oncol; 2017 Oct; 24(11):3167-3173. PubMed ID: 28699134
[TBL] [Abstract][Full Text] [Related]
2. Contrast-Enhanced Ultrasound Biopsy of Sentinel Lymph Nodes in Patients with Breast Cancer: Implications for Axillary Metastases and Conservation.
Cox K; Weeks J; Mills P; Chalmers R; Devalia H; Fish D; Sever A
Ann Surg Oncol; 2016 Jan; 23(1):58-64. PubMed ID: 25990967
[TBL] [Abstract][Full Text] [Related]
3. Real-time Visualization of Breast Carcinoma in Pathology Specimens From Patients Receiving Fluorescent Tumor-Marking Agent Tozuleristide.
Dintzis SM; Hansen S; Harrington KM; Tan LC; Miller DM; Ishak L; Parrish-Novak J; Kittle D; Perry J; Gombotz C; Fortney T; Porenta S; Hales L; Calhoun KE; Anderson BO; Javid SH; Byrd DR
Arch Pathol Lab Med; 2019 Sep; 143(9):1076-1083. PubMed ID: 30550350
[TBL] [Abstract][Full Text] [Related]
4. Surgical management of lobular carcinoma from a national screening program: a retrospective analysis.
Sharma SD; Barry M; O'Reilly EA; Kell MR
Eur J Surg Oncol; 2015 Jan; 41(1):79-85. PubMed ID: 25441933
[TBL] [Abstract][Full Text] [Related]
5. [Prognostic value of estrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 in node positive breast cancer patients treated by mastectomy].
Wang SL; Li YX; Song YW; Wang WH; Jin J; Liu YP; Liu XF; Yu ZH
Zhonghua Zhong Liu Za Zhi; 2010 Jul; 32(7):520-5. PubMed ID: 21029696
[TBL] [Abstract][Full Text] [Related]
6. Axillary lymph node recurrence after sentinel lymph node biopsy performed using a combination of indocyanine green fluorescence and the blue dye method in early breast cancer.
Inoue T; Nishi T; Nakano Y; Nishimae A; Sawai Y; Yamasaki M; Inaji H
Breast Cancer; 2016 Mar; 23(2):295-300. PubMed ID: 25348937
[TBL] [Abstract][Full Text] [Related]
7. Intraoperative Ultrasound-Guided Lumpectomy Versus Mammographic Wire Localization for Breast Cancer Patients After Neoadjuvant Treatment.
Rubio IT; Esgueva-Colmenarejo A; Espinosa-Bravo M; Salazar JP; Miranda I; Peg V
Ann Surg Oncol; 2016 Jan; 23(1):38-43. PubMed ID: 26514120
[TBL] [Abstract][Full Text] [Related]
8. Does a Positive Axillary Lymph Node Needle Biopsy Result Predict the Need for an Axillary Lymph Node Dissection in Clinically Node-Negative Breast Cancer Patients in the ACOSOG Z0011 Era?
Pilewskie M; Mautner SK; Stempel M; Eaton A; Morrow M
Ann Surg Oncol; 2016 Apr; 23(4):1123-8. PubMed ID: 26553439
[TBL] [Abstract][Full Text] [Related]
9. Palliative Local Surgery for Locally Advanced Breast Cancer Depending on Hormone Receptor Status in Elderly Patients.
Pan H; Zhang K; Wang M; Ling L; Zhou W; Wang S
Clin Breast Cancer; 2019 Feb; 19(1):e247-e260. PubMed ID: 30348592
[TBL] [Abstract][Full Text] [Related]
10. A Dutch Prediction Tool to Assess the Risk of Additional Axillary Non-Sentinel Lymph Node Involvement in Sentinel Node-Positive Breast Cancer Patients.
van den Hoven I; van Klaveren D; Voogd AC; Vergouwe Y; Tjan-Heijnen V; Roumen RM
Clin Breast Cancer; 2016 Apr; 16(2):123-30. PubMed ID: 26602438
[TBL] [Abstract][Full Text] [Related]
11. Implications of New Lumpectomy Margin Guidelines for Breast-Conserving Surgery: Changes in Reexcision Rates and Predicted Rates of Residual Tumor.
Merrill AL; Coopey SB; Tang R; McEvoy MP; Specht MC; Hughes KS; Gadd MA; Smith BL
Ann Surg Oncol; 2016 Mar; 23(3):729-34. PubMed ID: 26467458
[TBL] [Abstract][Full Text] [Related]
12. Characteristics and outcomes of sentinel node-positive breast cancer patients after total mastectomy without axillary-specific treatment.
Milgrom S; Cody H; Tan L; Morrow M; Pesce C; Setton J; Rogers K; Arnold B; Eaton A; Catalano J; McCormick B; Powell S; Ho A
Ann Surg Oncol; 2012 Nov; 19(12):3762-70. PubMed ID: 22576064
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of clinically node-negative breast cancer without axillary dissection: can preserved axilla be safely treated with radiation after a positive sentinel node biopsy?
Sanuki N; Takeda A; Amemiya A; Ofuchi T; Ono M; Ogata H; Yamagami R; Hatayama J; Eriguchi T; Kunieda E
Clin Breast Cancer; 2013 Feb; 13(1):69-76. PubMed ID: 23062706
[TBL] [Abstract][Full Text] [Related]
14. Impact of Consensus Guidelines by the Society of Surgical Oncology and the American Society for Radiation Oncology on Margins for Breast-Conserving Surgery in Stages 1 and 2 Invasive Breast Cancer.
Chung A; Gangi A; Amersi F; Bose S; Zhang X; Giuliano A
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S422-7. PubMed ID: 26310280
[TBL] [Abstract][Full Text] [Related]
15. Predicting axillary sentinel node status in patients with primary breast cancer.
Kolarik D; Pecha V; Skovajsova M; Zahumensky J; Trnkova M; Petruzelka L; Halaska M; Sottner O; Otcenasek M; Kolarova H
Neoplasma; 2013; 60(3):334-42. PubMed ID: 23374005
[TBL] [Abstract][Full Text] [Related]
16. Predictors of completion axillary lymph node dissection in patients with immunohistochemical metastases to the sentinel lymph node in breast cancer.
Pugliese MS; Karam AK; Hsu M; Stempel MM; Patil SM; Ho AY; Traina TA; Van Zee KJ; Cody HS; Morrow M; Gemignani ML
Ann Surg Oncol; 2010 Apr; 17(4):1063-8. PubMed ID: 20033325
[TBL] [Abstract][Full Text] [Related]
17. Role of re-excision for positive and close resection margins in patients treated with breast-conserving surgery.
Biglia N; Ponzone R; Bounous VE; Mariani LL; Maggiorotto F; Benevelli C; Liberale V; Ottino MC; Sismondi P
Breast; 2014 Dec; 23(6):870-5. PubMed ID: 25305040
[TBL] [Abstract][Full Text] [Related]
18. Management of positive margins after initial lumpectomy in elderly women with breast cancer.
Angarita FA; Acuna SA; McCready DR; Escallon J
Eur J Surg Oncol; 2018 Jul; 44(7):1048-1053. PubMed ID: 29525464
[TBL] [Abstract][Full Text] [Related]
19. The real-time intra-operative evaluation of sentinel lymph nodes in breast cancer patients using One Step Nucleic Acid Amplification (OSNA) and implications for clinical decision-making.
Chaudhry A; Williams S; Cook J; Jenkins M; Sohail M; Calder C; Winters ZE; Rayter Z
Eur J Surg Oncol; 2014 Feb; 40(2):150-7. PubMed ID: 24378008
[TBL] [Abstract][Full Text] [Related]
20. Differences in Response and Surgical Management with Neoadjuvant Chemotherapy in Invasive Lobular Versus Ductal Breast Cancer.
Truin W; Vugts G; Roumen RM; Maaskant-Braat AJ; Nieuwenhuijzen GA; van der Heiden-van der Loo M; Tjan-Heijnen VC; Voogd AC
Ann Surg Oncol; 2016 Jan; 23(1):51-7. PubMed ID: 25980321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]